Press Releases
Life Technologies Wins Top Ten Innovations of the Year Award
LifeTechnologies Corporation announced that its Applied Biosystems Attune(TM) Acoustic Focusing Cytometer has been named one of the Top Ten Innovations of 2010 by The Scientist Magazine. On an annual basis for the past three years, the publication gathers a...
Press Releases
Selcia and Gilead Sciences Extend Liver Disease Drug Discovery Collaboration
Selcia Limited, a leading contract research organisation, announced a drug discovery collaboration agreement with Gilead Sciences, Inc. Building on an established partnership following significant progress made to date, Selcia’s chemists and biologists will continue to provide integrated drug discovery...
Press Releases
Micell Technologies Enrolls First Patient in DESSOLVE I First-In-Human Study of MiStent DES
Micell Technologies,announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries),...
Press Releases
BG Medicine Announces FDA Clearance of its Galectin-3 Test for Use in Patients with Chronic HF
BG Medicine, Inc., a U.S.-based life sciences company, announced that the U.S. FDA has cleared the company’s Galectin-3 test for use in conjunction with clinical evaluation as an aid to assess the prognosis of patients diagnosed with chronic heart...
Press Releases
NanoString Launches First Simple and Precise Approach to Detect Hundreds of Genetic Copy Variants in a Single Multiplexed Reaction
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, announced the launch of a novel solution for detecting genetic copy number variations (CNVs)...
Press Releases
Merrion Pharmaceuticals Plc announces commencement of feasibility and option agreement with Rebel Pharmaceuticals
Merrion Pharmaceuticals Plc, a publicly listed product development company, announced the commencement of an oral drug delivery feasibility and option agreement with Rebel Pharmaceuticals, LLC, on two undisclosed compounds. The agreement will evaluate the ability of Merrion's patented GIPET®...
Press Releases
Reata and Abbott Announce Positive Phase 2b Study Results for Bardoxolone Methyl
Reata Pharmaceuticals and Abbott announced data from a Phase 2b study which suggests that bardoxolone methyl, an investigational treatment for chronic kidney disease (CKD), may reduce the stage of CKD and improve estimated glomerular filtration rate (eGFR) and other...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
